Exhibitor Showcase

English seminars or seminars with English interpretation

No. Date Time Seminar Title Register
Keynote/ Special Seminar
Special Seminar
1A-4 16 March (Mon.) 15:00
|
16:00
Mutagenic impurities and control strategy in the light of global regulatory aspects
Mr. E Sreedhar, Global Head of Regulatory Affairs, Regulatory Affairs, Dr. Reddy's Laboratories Ltd.
1A-6 17 March (Tue.) 13:00
|
14:30
【Sponsored by Japan Pharmaceutical Traders’ Association】 Beyond 2020-Change Control of APIs and International Procurement (Part 1)
1A-7 17 March (Tue.) 14:50
|
15:50
The future of oncology ~A focused approach to winning in 2030~
Mr. Junichi Kurihara, Partner, Head of Life Sciences, KPMG Japan
1A-8 17 March (Tue.) 16:15
|
18:00
【Sponsored by Japan Pharmaceutical Traders’ Association】 Beyond 2020-Change Control of APIs and International Procurement (Part 2)
APIC, CCCMHPIE, KPTA, JGA, JPMA, PMDA
1A-10 18 March (Wed.) 11:45
|
12:45
Global R&D And Clinical Trends – What Changed In 2019, And What To Look Out For In 2020
Mr. Ian Haydock, Editor in Chief, Asia-Pacific, Scrip/Pink sheet/In Vivo, Informa Pharma Intelligence
Conference
1B-3 16 March (Mon.) 13:15
|
14:15
Trends in Cell and Gene Therapy
Ms. Ly Nguyen-Jatkoe, Ph.D., Head of Content Strategy and thought leadership, Informa Pharma Intelligence
1B-7 17 March (Tue.) 11:45
|
12:45
China’s Pharmaceutical Market:  Policies, Impacts, Trends and Opportunities
Ms. Annie Siu, Ph.D., MBA, Principal Analyst, Informa Pharma Intelligence
1B-8 17 March (Tue.) 13:00
|
14:00
Novel Transdermal Drug Delivery: Advances in the Field and Challenges to Commercialization
Dr. Alan Smith, Chief Operating Officer, Nutriband and President, 4P Therapeutics Subsidiary of Nutriband, Editorial Advisory Board of Expert Opinion on Drug Delivery by Taylor & Francis
InnoPack Japan Conference
2E-10 17 March (Tue.) 15:30
|
16:20
Filling Vaccines with BFS
Mr. Klaus Schuster, Area Sales Manager, ROMMELAG Engineering
Biopharma Seminer
2H-13 18 March (Wed.) 13:00
|
14:10
Enabling cell & gene therapies commercialization through process  development and manufacturing industrialization
Ms. Lisa Krallis, Global Head of Business Development, Cell and Gene Technologies,  Lonza Pharma & Biotech | Lonza Japan Ltd.
Bioprocess and Analytical Method Development for Biologics and Biotech
3A-1 16 March (Mon.) 09:00
|
17:00
​Bioprocess and Analytical Method Development for Biologics and Biotec
3A-2 17 March (Tue.) 09:00
|
17:00
Continuous Manufacturing
Japan Life Science Week Seminar
Healthcare
6B-3 17 March (Tue.) 15:00
|
16:00
This seminar is cancelled due to unforeseen circumstances. Our journey to create Japan’s first hotpot for life sciences innovation Shonan iPark’s successes and challenges towards building a world-renowned ecosystem
Mr. Toshio ​Fujimoto, General Manager, Shonan Health Innovation Park, Takeda Pharmaceutical Company Limited
Close
6B-5 18 March (Wed.) 13:00
|
14:40
Germany’s Digital Health Market: Trends and Market Opportunities
Ms. Julia Pietsch, Senior Manager Digital Healthcare, Germany Trade & Invest
Pharmaceuticals
6B-1 16 March (Mon.) 13:00
|
14:30
Opportunities for Indo-Japan Partnerships in Healthcare
Dr. Gurpreet Sandhu, President, Council for Healthcare and Pharma (CHP)
6A-2 16 March (Mon.) 14:15
|
16:15
This seminar is cancelled due to unforeseen circumstances. Bio-pharmaceutical development technologies and services in Taiwan  
[Part-1] Ms. Pearl Fong Vice President, Business Development Center United BioPharma [Part-2] Dr. Hung-Jun, Lin Senior manager, Research and development department  Everest Pharm. Industrial Co., Ltd. [Part-3] Dr. Allen Ho Senior Director Regulatory Affairs & Analytical Operations JHL Biotech, Inc. [Part-4] Dr. Chih-Jung Chang COO EirGenix, INC.
Close